J Jaiswal1, K Dunlap2, M Griffin2, A Cox3, S N Singer4, K Hascher5, C LoSchiavo3, S M Walters6, M Mumba7. 1. Department of Health Science, University of Alabama, Tuscaloosa, AL 35401, USA; Center for Interdisciplinary Research on AIDS, Yale University School of Public Health, USA; Center for Drug Use and HIV/HCV Research, New York, NY, USA. Electronic address: jljaiswal@ua.edu. 2. Department of Health Science, University of Alabama, Tuscaloosa, AL 35401, USA. 3. Department of Health Behavior, Society and Policy, Rutgers University, Piscataway, NJ 08854, USA. 4. Graduate School of Applied & Professional Psychology, Rutgers University, 152 Frelinghuysen Road, Busch Campus, Piscataway, NJ 08854, USA. 5. Department of Biology, Department of Anthropology, University of Alabama, Tuscaloosa, AL 35401, USA. 6. Center for Drug Use and HIV/HCV Research, New York, NY, USA; Rory Meyers College of Nursing, New York University, New York, NY, USA. 7. Capstone College of Nursing, University of Alabama, Tuscaloosa, AL 35401, USA.
Abstract
BACKGROUND: HIV prevention is needed among people who use drugs (PWUD) due to mixing sex and drugs, selling/trading sex, and/or injecting drugs. Pre-exposure prophylaxis (PrEP) is an extremely effective biomedical HIV prevention strategy, but uptake remains low among communities most in need of HIV prevention, including PWUD. Previous studies have found that providers are less willing to prescribe PrEP to PWUD, yet PWUD express high levels of PrEP acceptance. More research is needed to understand how people who provide substance use treatment services think about PrEP to maximize this biomedical prevention strategy. METHODS: The study conducted semistructured interviews with 29 staff members in two methadone clinic settings in urban northern New Jersey. Staff members included medical providers, methadone counselors, intake coordinators, front desk staff, lab technicians, security guards, and administrative/leadership personnel. RESULTS: All staff recognized the need for HIV prevention among their patient populations, but most were either unaware of PrEP or unfamiliar with its purpose and how it works. Medical providers were more likely to have some PrEP knowledge in comparison to counselors and other staff, but the former largely did not have in-depth knowledge. Among those familiar with PrEP, many confused PrEP with HIV medication, as Truvada was the only FDA-approved PrEP at the time of the study. About half of participants expressed clear support for PrEP, while the other half expressed mixed or negative attitudes related to HIV, sexual behavior, and mistrust of the medication. Both the positive and negative perceptions entailed stigmatizing elements. RECOMMENDATIONS: Due to patients' frequent interactions with non-medical staff (e.g., front desk staff, lab technicians, etc.), all staff, not only medical personnel, should be aware of PrEP and comfortable discussing it to foster well-informed, nonjudgmental conversations about HIV prevention with patients. PrEP education should specifically address HIV and sexual-related stigma, as even positive perceptions of PrEP may entail stigmatizing elements.
BACKGROUND: HIV prevention is needed among people who use drugs (PWUD) due to mixing sex and drugs, selling/trading sex, and/or injecting drugs. Pre-exposure prophylaxis (PrEP) is an extremely effective biomedical HIV prevention strategy, but uptake remains low among communities most in need of HIV prevention, including PWUD. Previous studies have found that providers are less willing to prescribe PrEP to PWUD, yet PWUD express high levels of PrEP acceptance. More research is needed to understand how people who provide substance use treatment services think about PrEP to maximize this biomedical prevention strategy. METHODS: The study conducted semistructured interviews with 29 staff members in two methadone clinic settings in urban northern New Jersey. Staff members included medical providers, methadone counselors, intake coordinators, front desk staff, lab technicians, security guards, and administrative/leadership personnel. RESULTS: All staff recognized the need for HIV prevention among their patient populations, but most were either unaware of PrEP or unfamiliar with its purpose and how it works. Medical providers were more likely to have some PrEP knowledge in comparison to counselors and other staff, but the former largely did not have in-depth knowledge. Among those familiar with PrEP, many confused PrEP with HIV medication, as Truvada was the only FDA-approved PrEP at the time of the study. About half of participants expressed clear support for PrEP, while the other half expressed mixed or negative attitudes related to HIV, sexual behavior, and mistrust of the medication. Both the positive and negative perceptions entailed stigmatizing elements. RECOMMENDATIONS: Due to patients' frequent interactions with non-medical staff (e.g., front desk staff, lab technicians, etc.), all staff, not only medical personnel, should be aware of PrEP and comfortable discussing it to foster well-informed, nonjudgmental conversations about HIV prevention with patients. PrEP education should specifically address HIV and sexual-related stigma, as even positive perceptions of PrEP may entail stigmatizing elements.
Authors: E Jennifer Edelman; Brent A Moore; Sarah K Calabrese; Gail Berkenblit; Chinazo Cunningham; Viraj Patel; Karran Phillips; Jeanette M Tetrault; Minesh Shah; David A Fiellin; Oni Blackstock Journal: AIDS Behav Date: 2017-04
Authors: Keosha T Bond; Irene S Yoon; Steven T Houang; Martin J Downing; Christian Grov; Sabina Hirshfield Journal: Sex Res Social Policy Date: 2019-01-03
Authors: Sarah K Calabrese; Manya Magnus; Kenneth H Mayer; Douglas S Krakower; Adam I Eldahan; Lauren A Gaston Hawkins; Nathan B Hansen; Trace S Kershaw; Kristen Underhill; Joseph R Betancourt; John F Dovidio Journal: PLoS One Date: 2016-06-15 Impact factor: 3.240
Authors: Don C Des Jarlais; Jonathan P Feelemyer; Shilpa N Modi; Abu Abdul-Quader; Holly Hagan Journal: BMC Public Health Date: 2013-01-19 Impact factor: 3.295
Authors: Suzan M Walters; David Frank; Brent Van Ham; Jessica Jaiswal; Brandon Muncan; Valerie Earnshaw; John Schneider; Samuel R Friedman; Danielle C Ompad Journal: AIDS Behav Date: 2021-10-09
Authors: Suzan M Walters; Joey Platt; Amarachi Anakaraonye; Sarit A Golub; Chinazo O Cunningham; Brianna L Norton; Jae M Sevelius; Oni J Blackstock Journal: AIDS Behav Date: 2021-06-17